Azelby Robert
SEC insider (Form 3/4/5 filer). CIK 0001656998. Director at Autolus Therapeutics plc (AUTL) and 4 other issuers. 13 reported Form 4/5 transactions since Sep 2024; latest on Jun 29, 2026. Located in LONDON.
Companies Azelby Robert has filed insider reports for
- Autolus Therapeutics plc (AUTL): Director
- Tango Therapeutics, Inc. (TNGX): Director
- ADC Therapeutics SA (ADCT): Director
- Terns Pharmaceuticals, Inc. (TERN): Director
- CARDINAL HEALTH INC (CAH): Director
Azelby Robert
CIK: 0001656998
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 29, 2026AUTL
Autolus Therapeutics plc
AwardDirectRestricted Share Units
31.7K shares- - Jun 29, 2026AUTL
Autolus Therapeutics plc
AwardDirectShare Option (Right to Buy)
47.5K shares- - Jun 19, 2026TNGX
Tango Therapeutics, Inc.
AwardDirect5.7K shares- - Jun 3, 2026ADCT
ADC Therapeutics SA
Tax PaymentDirect12.6K shares at avg. $3.08$39K - Jun 1, 2026ADCT
ADC Therapeutics SA
AwardDirect45K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
1.7K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
90K shares- - Feb 1, 2026TERN
Terns Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
1.7K shares- - Nov 5, 2025CAH
CARDINAL HEALTH INC
AwardDirect1.1K shares- - Jun 13, 2025ADCT
ADC Therapeutics SA
Tax PaymentDirect12.6K shares at avg. $3.58$45K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 29, 2026 |  AUTL Autolus Therapeutics plc | Award Restricted Share Units | 31,667 | - | - | Direct |
| Jun 29, 2026 | AUTL Autolus Therapeutics plc | Award Share Option (Right to Buy) | 47,500 | - | - | Direct |
| Jun 19, 2026 |  TNGX Tango Therapeutics, Inc. | Award | 5,740 | - | $0 | Direct |
| Jun 3, 2026 |  ADCT ADC Therapeutics SA | Tax Payment | 12,600 | $3.08 | $38,808 | Direct |
| Jun 1, 2026 | ADCT ADC Therapeutics SA | Award | 45,000 | - | $0 | Direct |
| May 5, 2026 |  TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 1,697 | - | - | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 90,000 | - | - | Direct |
| Feb 1, 2026 | TERN Terns Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 1,697 | - | - | Direct |
| Nov 5, 2025 |  CAH CARDINAL HEALTH INC | Award | 1,067 | - | - | Direct |
| Jun 13, 2025 | ADCT ADC Therapeutics SA | Tax Payment | 12,600 | $3.58 | $45,108 | Direct |
1-10 of 13 transactions